Beau's Toes

Affiliations

¹ Department of Internal Medicine, School of Medicine, University of California, Davis, 4150 V street, Suite 1100, Sacramento, CA, 95817, USA. cpiao@ucdavis.edu.
² Department of Internal Medicine, School of Medicine, University of California, Davis, 4150 V street, Suite 1100, Sacramento, CA, 95817, USA.

Cindy Piao et al. J Gen Intern Med. 2020 Aug.

. 2020 Aug;35(8):2467.

doi: 10.1007/s11606-020-05883-2. Epub 2020 May 28.

¹ Department of Internal Medicine, School of Medicine, University of California, Davis, 4150 V street, Suite 1100, Sacramento, CA, 95817, USA. cpiao@ucdavis.edu.
² Department of Internal Medicine, School of Medicine, University of California, Davis, 4150 V street, Suite 1100, Sacramento, CA, 95817, USA.

No abstract available

Conflict of interest statement

The authors declare that they do not have a conflict of interest.

1. Piraccini BM, Iorizzo M, Starace M, Tosti A. Drug-induced Nail Diseases. Dermatol Clin. 2006;24(3):387–391. doi: 10.1016/J.DET.2006.03.004. - DOI - PubMed
1. Zaiac MN, Walker A. Nail abnormalities associated with systemic pathologies. Clin Dermatol. 2013;31(5):627–649. doi: 10.1016/J.CLINDERMATOL.2013.06.018. - DOI - PubMed
1. Hinds G, Thomas VD. Malignancy and Cancer Treatment-Related Hair and Nail Changes. Dermatol Clin. 2008;26(1):59–68. doi: 10.1016/J.DET.2007.08.003. - DOI - PubMed
1. Yaemsiri S, Hou N, Slining M, He K. Growth rate of human fingernails and toenails in healthy American young adults. J Eur Acad Dermatology Venereol. 2010;24(4):420–423. doi: 10.1111/j.1468-3083.2009.03426.x. - DOI - PubMed
1. Robert C, Sibaud V, Mateus C, et al. Nail toxicities induced by systemic anticancer treatments. Lancet Oncol. 2015;16(4):e181–9. doi: 10.1016/S1470-2045(14)71133-7. - DOI - PubMed